Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(50.0%)
Phase 2
1(50.0%)
2Total
Phase 3(1)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04102371Phase 3Completed

Pragmatic Pediatric Trial of Balanced Versus Normal Saline Fluid in Sepsis

Role: collaborator

NCT02318030Completed

CNTRP POSITIVE Study

Role: collaborator

NCT01429415Phase 2Completed

Magnesium Nebulization Utilization in Management of Pediatric Asthma

Role: collaborator

NCT02847884Completed

IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study

Role: collaborator

NCT02162147Completed

How Safe Are Our Pediatric Emergency Departments?

Role: collaborator

All 5 trials loaded